1. Home
  2. CART vs RDY Comparison

CART vs RDY Comparison

Compare CART & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maplebear Inc.

CART

Maplebear Inc.

N/A

Current Price

$56.39

Market Cap

10.5B

Sector

N/A

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$14.18

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CART
RDY
Founded
2012
1984
Country
United States
India
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
9.9B
IPO Year
2023
2001

Fundamental Metrics

Financial Performance
Metric
CART
RDY
Price
$56.39
$14.18
Analyst Decision
Buy
Buy
Analyst Count
30
5
Target Price
★ $58.56
$14.26
AVG Volume (30 Days)
★ 6.1M
2.9M
Earning Date
10-29-2026
10-23-2026
Dividend Yield
N/A
★ 0.46%
EPS Growth
★ 1.27
N/A
EPS
★ 1.02
N/A
Revenue
★ $3,742,000,000.00
N/A
Revenue This Year
$14.60
$4.59
Revenue Next Year
$10.23
$12.06
P/E Ratio
$56.19
★ $18.67
Revenue Growth
★ 10.78
N/A
52 Week Low
$32.73
$11.36
52 Week High
$61.73
$15.67

Technical Indicators

Market Signals
Indicator
CART
RDY
Relative Strength Index (RSI) 63.94 77.10
Support Level $38.62 $13.99
Resistance Level N/A $14.20
Average True Range (ATR) 2.61 0.23
MACD 0.76 0.11
Stochastic Oscillator 60.75 89.58

Price Performance

Historical Comparison
CART
RDY

About CART Maplebear Inc.

Maplebear (Instacart) is a grocery-focused delivery marketplace that connects national and regional grocers with consumers and couriers, and consumers with their favorite stores. Its app provides on-demand convenience for consumers, lets couriers earn income, and helps grocers scale through digital channels. The marketplace gathers valuable consumer behavior data, attracting consumer-packaged-goods advertisers that seek to reach consumers at the point of purchase. With approximately 600,000 shoppers and 2,200 retail partners, Instacart delivers to about 98% of households in the United States and Canada.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: